Potential Hazards of Fixed Gain Sensing and Arrhythmia Reconfirmation for Implantable Cardioverter Defibrillators
- 1 May 1993
- journal article
- case report
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 16 (5) , 1070-1079
- https://doi.org/10.1111/j.1540-8159.1993.tb04583.x
Abstract
Appropriate sensing of ventricular tachycardia (VT) and ventricular fibrillation (VF) is of paramount importance for safety of patients with implanted cardioverter defibrillators (ICDs). Recently, the GuardianR ATP 4210, a new third generation ICD that uses programmable but fixed sensing during sinus rhythm and doubles its sensitivity settings when VF is detected, to a maximum programmable sensitivity of 1 mV, has been tested in phase I and II clinical trials. A reconfirmation algorithm of this ICD confirms the presence of VT or VF prior to therapy. This case report describes undersensing of VF in a patient with the GuardianR ATP 4210 at the maximum programmed sensitivity of 1 mV. Inappropriate episodes of asystole and prolonged bradycardias were also observed in this patient due to shortcomings in the reconfirmation algorithm design. Reoperation was required, with positioning of a new endocardial sensing lead to correct the undersensing of VF. This, however, did not correct asystolic pauses following antitachycardia pacing or spontaneous tachycardia termination prior to therapy. This case report highlights the hazards of fixed gain sensing for implantable ICDs and a potential limitation of a specific tachyarrhythmia reconfirmation algorithm used in this device.Keywords
This publication has 11 references indexed in Scilit:
- Failure of a Second and Third Generation Implantable Cardioverter Defibrillator to Sense Ventricular Tachycardia: Implications for Fixed-Gain Sensing DevicesPacing and Clinical Electrophysiology, 1992
- Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testingJournal of the American College of Cardiology, 1992
- The Initial Clinical Experience with an Implantable Cardioverter Defibrillator/ Antitachycardia PacemakerPacing and Clinical Electrophysiology, 1991
- State‐of‐the‐Art of the AICDPacing and Clinical Electrophysiology, 1991
- Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac diseaseJournal of the American College of Cardiology, 1990
- Long-term outcome with the automatic implantable cardioverter-defibrillatorJournal of the American College of Cardiology, 1989
- Implanted Automatic Defibrillators: Effects of Drugs and PacemakersPacing and Clinical Electrophysiology, 1988
- Implantable Defibrillation: Eight Years Clinical ExperiencePacing and Clinical Electrophysiology, 1988
- The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarctionThe American Journal of Cardiology, 1988
- Clinical Performance of the Implantable Cardioverter‐DefibrillatorPacing and Clinical Electrophysiology, 1984